QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.

Clinical trial NCT03552718 · COMPLETED

Trial details

NCT number: NCT03552718
Sponsor: NantBioScience, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Breast Cancer Head and Neck Squamous Cell Carcinoma Melanoma Non Small Cell Lung Cancer Pancreatic Cancer Liver Cancer

Start date: 2018-08-10
Primary completion: 2025-03-18
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.